U.S. markets open in 2 hours 6 minutes
  • S&P Futures

    3,890.75
    -8.00 (-0.21%)
     
  • Dow Futures

    31,473.00
    -36.00 (-0.11%)
     
  • Nasdaq Futures

    13,247.50
    -32.25 (-0.24%)
     
  • Russell 2000 Futures

    2,262.40
    -12.40 (-0.55%)
     
  • Crude Oil

    60.75
    +0.11 (+0.18%)
     
  • Gold

    1,727.10
    +4.10 (+0.24%)
     
  • Silver

    26.37
    -0.31 (-1.15%)
     
  • EUR/USD

    1.2034
    -0.0026 (-0.22%)
     
  • 10-Yr Bond

    1.4460
    0.0000 (0.00%)
     
  • Vix

    23.20
    -4.75 (-16.99%)
     
  • GBP/USD

    1.3921
    0.0000 (-0.00%)
     
  • USD/JPY

    106.9410
    +0.2110 (+0.20%)
     
  • BTC-USD

    48,732.05
    +979.66 (+2.05%)
     
  • CMC Crypto 200

    981.13
    -5.52 (-0.56%)
     
  • FTSE 100

    6,629.02
    +40.49 (+0.61%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

Aurinia (AUPH) Looks Good: Stock Adds 5.5% in Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Aurinia Pharmaceuticals Inc. AUPH was a big mover last session, as the company saw its shares more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This stock, which remained volatile and traded within the range of $12.94 –$15.20 in the past one-month time frame, witnessed a sharp increase on Thursday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Aurinia has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Aurinia Pharmaceuticals Inc Price

Aurinia Pharmaceuticals Inc Price
Aurinia Pharmaceuticals Inc Price

Aurinia Pharmaceuticals Inc price | Aurinia Pharmaceuticals Inc Quote

Investors interested in the Medical - Drugs industry may consider Catalent, Inc. CTLT which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Aurinia Pharmaceuticals Inc (AUPH) : Free Stock Analysis Report
 
Catalent, Inc. (CTLT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research